Tirzepatide 10mg

Description

Tirzepatide 10mg: Precision Dual GIP/GLP-1 Agonist for Baseline Assays

Tirzepatide (10mg) is a synthetic linear peptide engineered specifically for high-precision in-vitro research into metabolic signaling pathways. Functioning as a dual agonist for both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, this compound enables principal investigators to study co-agonist binding dynamics within controlled cellular environments.

The 10mg vial format is ideal for standard baseline assays, initial titration studies, and single-plate cell culture experiments. In laboratory settings, researchers apply this compound to isolated pancreatic $\beta$-cell cultures to quantify cyclic adenosine monophosphate (cAMP) generation, observe receptor internalization kinetics, and evaluate intracellular downstream signaling cascades.

• Application: In-vitro metabolic research, receptor-binding assays, and intracellular pathway mapping.

• Target: Dual agonist for GIP and GLP-1 receptors.

• Quantity: 10mg lyophilized peptide per vial.

• Purity Standard: Independently verified via HPLC and Mass Spectrometry for institutional research.